Company profile: ChemoCentryx
1.1 - Company Overview
Company description
- Provider of orally administered small-molecule therapeutics targeting chemokine and related chemo-attractant receptors for inflammatory and autoimmune diseases and cancer, focusing on the discovery, development and commercialization of new medications.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ChemoCentryx
Santa Ana Bio
HQ: United States
Website
- Description: Provider of precision immunology drug development for autoimmune and inflammatory diseases, using single-cell genomics and advanced analytics to develop drugs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Santa Ana Bio company profile →
Euroimmun
HQ: Germany
Website
- Description: Provider of medical laboratory diagnostics, designing, manufacturing, and selling disease detection test systems, with software and automation for test execution and evaluation. Products are used to diagnose autoimmune and infectious diseases; offerings include EURORealTime APOE, EURORealTime RSV A/B, SwiftX-traction, Chemiluminescence Immunoassays (ChLIA), and training via EUROIMMUN Academy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Euroimmun company profile →
Granite Bio
HQ: Switzerland
Website
- Description: Provider of novel antibody-based biotechnology to treat inflammatory, autoimmune, and fibrotic disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Granite Bio company profile →
Promedior
HQ: United States
Website
- Description: Provider of clinical-stage biopharmaceutical therapeutics for inflammatory and fibrotic diseases, supported by a novel drug discovery platform to regulate monocyte-derived cell populations that play key roles in fibrotic, inflammatory and autoimmune diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Promedior company profile →
Sitryx
HQ: United Kingdom
Website
- Description: Provider of cell metabolism–targeted, first-in-class, disease-modifying therapeutics in immuno-oncology and immuno-inflammation. Pipeline includes SYX-5219 for atopic dermatitis; SIT-052, an inhaled GLS1 inhibitor for pulmonary fibrosis and COPD that selectively breaks down senescent cells; SIT-033, a SIK2 inhibitor for ulcerative colitis; and SYX-1042 and SIT-047 for autoimmune indications (with Eli Lilly).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sitryx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ChemoCentryx
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ChemoCentryx
2.2 - Growth funds investing in similar companies to ChemoCentryx
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ChemoCentryx
4.2 - Public trading comparable groups for ChemoCentryx
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →